Korean Stock
EXCH
SK Biopharmaceuticals
★
Investor Relations (IR) Event - Domestic NDR
 05/19/2026, 10:31 AM
PERI
SK Biopharmaceuticals
★★★
SK Biopharmaceuticals Q1 2026: Operating Profit of KRW 89.8B on Strong Cenobamate Sales
 05/15/2026, 03:16 PM
EXCH
SK Biopharmaceuticals
★
IR Conference Call for 2025 Q4 and Annual Earnings
 05/10/2026, 07:00 PM
EXCH
SK Biopharmaceuticals
★★★★
SK Biopharm Q1 2026 Results: Revenue and Operating Profit Surge, Net Income Up 423.5% YoY
 05/07/2026, 09:50 AM
EXCH
SK Biopharmaceuticals
★
2026 Q1 Earnings Results IR Meeting
 05/04/2026, 09:42 AM